/images/ppid_59c68470-image-179370004174842952.webp)
/images/ppid_59c68470-image-179363256783897680.webp)
What is the story about?
Drug firm Pfizer Ltd
on Tuesday (November 3) reported a 65.6% year-on-year (YoY) increase in net profit (PAT) at ₹313 crore for the second quarter, compared with ₹189 crore in the corresponding quarter last year.
The company reported a one-time gain of ₹132 crore during the quarter. Revenue from operations (GU) rose 13.2% to ₹727 crore from ₹642 crore in the year-ago period.
Earnings before interest, tax, depreciation and amortisation (EBITDA) increased 14.4% YoY to ₹262 crore from ₹229 crore. EBITDA margin remained flat at 36% compared with the corresponding quarter last year.
Shares of Pfizer Ltd ended at ₹3,770.00, up by ₹132.10, or 3.63%, on the BSE.
The company reported a one-time gain of ₹132 crore during the quarter. Revenue from operations (GU) rose 13.2% to ₹727 crore from ₹642 crore in the year-ago period.
Earnings before interest, tax, depreciation and amortisation (EBITDA) increased 14.4% YoY to ₹262 crore from ₹229 crore. EBITDA margin remained flat at 36% compared with the corresponding quarter last year.
Shares of Pfizer Ltd ended at ₹3,770.00, up by ₹132.10, or 3.63%, on the BSE.
/images/ppid_59c68470-image-179372752132210714.webp)
/images/ppid_59c68470-image-179378010857648897.webp)
/images/ppid_59c68470-image-179378252946185335.webp)
/images/ppid_59c68470-image-179376764155395067.webp)
/images/ppid_59c68470-image-17937200247963968.webp)
/images/ppid_59c68470-image-179371002860386189.webp)
